# Gut-Associated Lymphocyte Trafficking

> **NCT02906137** · NA · COMPLETED · sponsor: **ANRS, Emerging Infectious Diseases** · enrollment: 80 (actual)

## Conditions studied

- HIV-1 Infection

## Interventions

- **OTHER:** Peripheral blood and intestinal biopsies will be collected

## Key facts

- **NCT ID:** NCT02906137
- **Lead sponsor:** ANRS, Emerging Infectious Diseases
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-06
- **Primary completion:** 2020-02-25
- **Final completion:** 2020-02-25
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2026-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02906137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02906137, "Gut-Associated Lymphocyte Trafficking". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02906137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
